Lyme disease

Lantos PM, Rumbaugh J, Bockenstedt LK, et al. Clinical practice guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 guidelines for the prevention, diagnosis and treatment of Lyme disease. Clin Infect Dis. 2021 Jan 23;72(1):e1-48.Texto completo  Resumen

Mead P, Petersen J, Hinckley A. Updated CDC recommendation for serologic diagnosis of lyme disease. MMWR Morb Mortal Wkly Rep. 2019 Aug 16;68(32):703.Texto completo  Resumen

Mygland A, Ljøstad U, Fingerle V, et al; European Federation of Neurological Societies. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol. 2010 Jan;17(1):8-16;e1-4.Texto completo  Resumen

National Institute for Health and Care Excellence. Lyme disease. Oct 2018 [internet publication].Texto completo

1. Kullberg BJ, Vrijmoeth HD, van de Schoor F, et al. Lyme borreliosis: diagnosis and management. BMJ. 2020 May 26;369:m1041.Texto completo  Resumen

2. Tibbles CD, Edlow JA. Does this patient have erythema migrans? JAMA. 2007 Jun 20;297(23):2617-27. Resumen

3. Marques AR, Strle F, Wormser GP. Comparison of lyme disease in the United States and Europe. Emerg Infect Dis. 2021 Aug;27(8):2017-24.Texto completo  Resumen

4. Ogrinc K, Lusa L, Lotrič-Furlan S, et al. Course and outcome of early European lyme neuroborreliosis (Bannwarth Syndrome): clinical and laboratory findings. Clin Infect Dis. 2016 Aug 1;63(3):346-53.Texto completo  Resumen

5. Nau R, Christen HJ, Eiffert H. Lyme disease: current state of knowledge. Dtsch Arztebl Int. 2009 Jan;106(5):72-81;quiz 82, I.Texto completo  Resumen

6. Schwartz AM, Hinckley AF, Mead PS, et al. Surveillance for Lyme disease - United States, 2008-2015. MMWR Surveill Summ. 2017 Nov 10;66(22):1-12.Texto completo  Resumen

7. Centers for Disease Control and Prevention. Data and surveillance. Aug 2022 [internet publication].Texto completo

8. Kugeler KJ, Schwartz AM, Delorey MJ, et al. Estimating the frequency of lyme disease diagnoses, United States, 2010-2018. Emerg Infect Dis. 2021 Feb;27(2):616-19.Texto completo  Resumen

9. World Health Organization. Lyme borreliosis in Europe: influences of climate and climate change epidemiology, ecology and adaptation measures. Sep 2006 [internet publication].Texto completo

10. Sykes RA, Makiello P. An estimate of Lyme borreliosis incidence in Western Europe†. J Public Health (Oxf). 2017 Mar 1;39(1):74-81.Texto completo  Resumen

11. Burn L, Vyse A, Pilz A, et al. Incidence of lyme borreliosis in Europe: a systematic review (2005-2020). Vector Borne Zoonotic Dis. 2023 Apr;23(4):172-94.Texto completo  Resumen

12. Rosenberg R, Lindsey NP, Fischer M, et al. Vital signs: trends in reported vectorborne disease cases - United States and Territories, 2004-2016. MMWR Morb Mortal Wkly Rep. 2018 May 4;67(17):496-501.Texto completo  Resumen

13. Thomson MC, Stanberry LR. Climate change and vectorborne diseases. N Engl J Med. 2022 Nov 24;387(21):1969-78.Texto completo  Resumen

14. Steere AC, McHugh G, Suarez C, et al. Prospective study of coinfection in patients with erythema migrans. Clin Infect Dis. 2003 Apr 15;36(8):1078-81.Texto completo  Resumen

15. Pritt BS, Mead PS, Johnson DK, et al. Identification of a novel pathogenic Borrelia species causing Lyme borreliosis with unusually high spirochaetaemia: a descriptive study. Lancet Infect Dis. 2016 May;16(5):556-64.Texto completo  Resumen

16. Wormser GP. A brief history of OspA vaccines including their impact on diagnostic testing for Lyme disease. Diagn Microbiol Infect Dis. 2022 Jan;102(1):115572.Texto completo  Resumen

17. McVicar M, Rivera I, Reyes JB, et al. Ecology of ixodes pacificus ticks and associated pathogens in the Western United States. Pathogens. 2022 Jan 13;11(1).Texto completo  Resumen

18. Singh SK, Girschick HJ. Lyme borreliosis: from infection to autoimmunity. Clin Microbiol Infect. 2004;10:598-614. Resumen

19. Steere AC, Coburn J, Glickstein L. The emergence of Lyme disease. J Clin Invest. 2004 Apr;113(8):1093-101.Texto completo  Resumen

20. Halsey SJ, Allan BF, Miller JR. The role of Ixodes scapularis, Borrelia burgdorferi and wildlife hosts in lyme disease prevalence: a quantitative review. Ticks Tick Borne Dis. 2018 Jul;9(5):1103-14.Texto completo  Resumen

21. Oliver JD, Bennett SW, Beati L, et al. Range expansion and increasing Borrelia burgdorferi infection of the tick ixodes scapularis (acari: ixodidae) in Iowa, 1990-2013. J Med Entomol. 2017 Nov 7;54(6):1727-34.Texto completo  Resumen

22. Hayes EB, Piesman J. How can we prevent Lyme disease? N Engl J Med. 2003 Jun 12;348(24):2424-30. Resumen

23. Daltroy LH, Phillips C, Lew R, et al. A controlled trial of a novel primary prevention program for Lyme disease and other tick-borne illnesses. Health Educ Behav. 2007 Jun;34(3):531-42. Resumen

24. Bratton RL, Whiteside JW, Hovan MJ, et al. Diagnosis and treatment of Lyme disease. Mayo Clin Proc. 2008 May;83(5):566-71.Texto completo  Resumen

25. Lantos PM, Rumbaugh J, Bockenstedt LK, et al. Clinical practice guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 guidelines for the prevention, diagnosis and treatment of Lyme disease. Clin Infect Dis. 2021 Jan 23;72(1):e1-48.Texto completo  Resumen

26. Razai MS, Doerholt K, Galiza E, et al. Tick bite. BMJ. 2020 Aug 13;370:m3029.Texto completo  Resumen

27. Dessau RB, van Dam AP, Fingerle V, et al. To test or not to test? Laboratory support for the diagnosis of Lyme borreliosis: a position paper of ESGBOR, the ESCMID study group for Lyme borreliosis. Clin Microbiol Infect. 2018 Feb;24(2):118-24.Texto completo  Resumen

28. Centers for Disease Control and Prevention. Lyme disease. May 2024 [internet publication].Texto completo

29. American College of Rheumatology – Pediatric Rheumatology. Five things physicians and patients should question. Choosing Wisely, an initiative of the ABIM Foundation. 2021 [internet publication].Texto completo

30. American Academy of Pediatrics - Section on Rheumatology. Five things physicians and patients should question. Choosing Wisely, an initiative of the ABIM Foundation. 2022 [internet publication].Texto completo

31. Centers for Disease Control and Prevention. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR Morb Mortal Wkly Rep. 1995 Aug 11;44(31):590-1.Texto completo  Resumen

32. Miller JM, Binnicker MJ, Campbell S, et al. Guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2024 update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM). Clin Infect Dis. 2024 Mar 5:ciae104.Texto completo  Resumen

33. Mead P, Petersen J, Hinckley A. Updated CDC recommendation for serologic diagnosis of lyme disease. MMWR Morb Mortal Wkly Rep. 2019 Aug 16;68(32):703.Texto completo  Resumen

34. Moore A, Nelson C, Molins C, et al. Current guidelines, common clinical pitfalls, and future directions for laboratory diagnosis of Lyme disease, United States. Emerg Infect Dis. 2016 Jul;22(7):1169–77.Texto completo  Resumen

35. American Society for Microbiology. Five things physicians and patients should question. Choosing Wisely, an initiative of the ABIM Foundation. 2022​ [internet publication].Texto completo

36. Mygland A, Ljøstad U, Fingerle V, et al; European Federation of Neurological Societies. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol. 2010 Jan;17(1):8-16;e1-4.Texto completo  Resumen

37. Branda JA, Steere AC. Laboratory diagnosis of Lyme borreliosis. Clin Microbiol Rev. 2021 Jan 27 [Epub ahead of print]. Resumen

38. Aguero-Rosenfeld ME, Wang G, Schwartz I, et al. Diagnosis of Lyme borreliosis. Clin Microbiol Rev. 2005 Jul;18(3):484-509.Texto completo  Resumen

39. Government of Canada. Lyme disease. October 2019 [internet publication].Texto completo

40. Huppertz HI, Bartmann P, Heininger U, et al. Rational diagnostic strategies for Lyme borreliosis in children and adolescents: recommendations by the Committee for Infectious Diseases and Vaccinations of the German Academy for Pediatrics and Adolescent Health. Eur J Pediatr. 2012 Nov;171(11):1619-24.Texto completo  Resumen

41. Steere AC, Malawista SE, Newman JH, et al. Antibiotic therapy in Lyme disease. Ann Intern Med. 1980 Jul;93(1):1-8. Resumen

42. Steere AC, Hutchinson GJ, Rahn DW, et al. Treatment of early manifestations of Lyme disease. Ann Intern Med. 1983 Jul;99(1):22-6. Resumen

43. Massarotti EM, Luger SW, Rahn DW, et al. Treatment of early Lyme disease. Am J Med. 1992 Apr;92(4):396-403. Resumen

44. Nadelman RB, Luger SW, Frank E, et al. Comparison of cefuroxime axetil and doxycycline in the treatment of early Lyme disease. Ann Intern Med. 1992 Aug 15;117(4):273-80. Resumen

45. Luger SW, Paparone P, Wormser GP, et al. Comparison of cefuroxime axetil and doxycycline in treatment of patients with early Lyme disease associated with erythema migrans. Antimicrob Agents Chemother. 1995 Mar;39(3):661-7.Texto completo  Resumen

46. Nowakowski J, Nadelman RB, Forseter G, et al. Doxycycline versus tetracycline therapy for Lyme disease associated with erythema migrans. J Am Acad Dermatol. 1995 Feb;32(2 Pt 1):223-7. Resumen

47. Eppes SC, Childs JA. Comparative study of cefuroxime axetil versus amoxicillin in children with early Lyme disease. Pediatrics. 2002 Jun;109(6):1173-7. Resumen

48. Wormser GP, Ramanathan R, Nowakowski J, et al. Duration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2003 May 6;138(9):697-704. Resumen

49. National Institute for Health and Care Excellence. Lyme disease. Oct 2018 [internet publication].Texto completo

50. Stupica D, Collinet-Adler S, Blagus R, et al. Treatment of erythema migrans with doxycycline for 7 days versus 14 days in Slovenia: a randomised open-label non-inferiority trial. Lancet Infect Dis. 2023 Mar;23(3):371-79.Texto completo  Resumen

51. American Academy of Pediatrics. Red book 2024-2027: ​report of the committee on infectious diseases. May 2024 [internet publication].Texto completo

52. Luft BJ, Dattwyler RJ, Johnson RC, et al. Azithromycin compared with amoxicillin in the treatment of erythema migrans. A double-blind, randomized, controlled trial. Ann Intern Med. 1996 May 1;124(9):785-91.Texto completo  Resumen

53. Berende A, Ter Hofstede HJM, Vos FJ, et al. Effect of prolonged antibiotic treatment on cognition in patients with Lyme borreliosis. Neurology. 2019 Mar 26;92(13):e1447-55.Texto completo  Resumen

54. Todd SR, Dahlgren FS, Traeger MS, et al. No visible dental staining in children treated with doxycycline for suspected Rocky Mountain spotted fever. J Pediatr. 2015 May;166(5):1246-51.Texto completo  Resumen

55. Ravindra D, Huang G, Hallett K, et al. Antibiotic exposure and dental health: a systematic review. Pediatrics. 2023 Jul 1;152(1):e2023061350.Texto completo  Resumen

56. Waddell LA, Greig J, Lindsay LR, et al. A systematic review on the impact of gestational Lyme disease in humans on the fetus and newborn. PLoS One. 2018 Nov 12;13(11):e0207067.Texto completo  Resumen

57. Nadelman RB, Nowakowski J, Fish D, et al; Tick Bite Study Group. Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite. N Engl J Med. 2001 Jul 12;345(2):79-84.Texto completo  Resumen

58. Steere AC, Levin RE, Molloy PJ, et al. Treatment of Lyme arthritis. Arthritis Rheum. 1994 Jun;37(6):878-88. Resumen

59. Eckman MH, Steere AC, Kalish RA, et al. Cost effectiveness of oral as compared with intravenous antibiotic treatment for patients with early Lyme disease or Lyme arthritis. N Engl J Med. 1997 Jul 31;337(5):357-63.Texto completo  Resumen

60. Cameron DJ, Johnson LB, Maloney EL. Evidence assessments and guideline recommendations in Lyme disease: the clinical management of known tick bites, erythema migrans rashes and persistent disease. Expert Rev Anti Infect Ther. 2014 Sep;12(9):1103-35.Texto completo  Resumen

61. Torbahn G, Hofmann H, Rücker G, et al. Efficacy and Safety of Antibiotic Therapy in Early Cutaneous Lyme Borreliosis: a network meta-analysis. JAMA Dermatol. 2018 Nov 1;154(11):1292-303.Texto completo  Resumen

62. Cardenas-de la Garza JA, De la Cruz-Valadez E, Ocampo-Candiani J, et al. Clinical spectrum of Lyme disease. Eur J Clin Microbiol Infect Dis. 2019 Feb;38(2):201-8.Texto completo  Resumen

63. Nemeth J, Bernasconi E, Heininger U, et al. Update of the Swiss guidelines on post-treatment Lyme disease syndrome. Swiss Med Wkly. 2016 Dec 5;146:w14353.Texto completo  Resumen

64. Eliassen KE, Hjetland R, Reiso H, et al. Symptom load and general function among patients with erythema migrans: a prospective study with a 1-year follow-up after antibiotic treatment in Norwegian general practice. Scand J Prim Health Care. 2017 Mar;35(1):75-83.Texto completo  Resumen

65. Berende A, ter Hofstede HJ, Vos FJ, et al. Randomized trial of longer-term therapy for symptoms attributed to Lyme disease. N Engl J Med. 2016;374:1209-1220.Texto completo  Resumen

66. Aucott JN. Posttreatment Lyme disease syndrome. Infect Dis Clin North Am. 2015 Jun;29(2):309-23.Texto completo  Resumen

67. Mead P. Epidemiology of lyme disease. Infect Dis Clin North Am. 2022 Sep;36(3):495-521.Texto completo  Resumen

68. Steere AC, Glickstein L. Elucidation of Lyme arthritis. Nat Rev Immunol. 2004 Feb;4(2):143-52.Texto completo  Resumen

69. Koedel U, Fingerle V, Pfister HW. Lyme neuroborreliosis-epidemiology, diagnosis and management. Nat Rev Neurol. 2015 Aug;11(8):446-56.Texto completo  Resumen

70. Asbrink E, Hovmark A, Olsson I. Clinical manifestations of acrodermatitis chronica atrophicans in 50 Swedish patients. Zentralbl Bakteriol Mikrobiol Hyg A. 1986 Dec;263(1-2):253-61.Texto completo  Resumen

71. Dattwyler RJ, Halperin JJ, Volkman DJ, et al. Treatment of late Lyme borreliosis - randomized comparison of ceftriaxone and penicillin. Lancet. 1988 May 28;1(8596):1191-4. Resumen

72. Dattwyler RJ, Wormser GP, Rush TJ, et al. A comparison of two treatment regimens of ceftriaxone in late Lyme disease. Wien Klin Wochenschr. 2005 Jun;117(11-12):393-7. Resumen

73. Scheffold N, Herkommer B, Kandolf R, et al. Lyme carditis--diagnosis, treatment and prognosis. Dtsch Arztebl Int. 2015 Mar 20;112(12):202-8.Texto completo  Resumen

74. Berende A, ter Hofstede HJ, Vos FJ, et al. Randomized trial of longer-term therapy for symptoms attributed to Lyme disease. N Engl J Med. 2016 Mar 31;374(13):1209-20.Texto completo  Resumen

75. Marzec NS, Nelson C, Waldron PR, et al. Serious bacterial infections acquired during treatment of patients given a diagnosis of chronic Lyme disease - United States. MMWR Morb Mortal Wkly Rep. 2017 Jun 16;66(23):607-9.Texto completo  Resumen